Brian Coleman (00:05):
Some of the biggest challenges right now is the healthcare market itself. It’s not just GLP ones, even though it’s a very large part of our pharmacy spend. We have other specialty meds that are over a million dollars for one family. We also are looking at, we’ve reduced emergency room, all of those things that are expensive. We’ve actually had a reduction in the last two years in usage. However, the costs have all gone up.